Schrödinger, Inc. (SDGR) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Schrödinger, Inc. · Health Care · ref. ETF XLV · 52 calls · price $20.41
What the company does: Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally.
📈 Schrödinger, Inc. (SDGR) stock price
$20.41+3.3% over range
Aug 28, 25low $11.07 · high $22.52Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
33% recommend buying · 3 analysts
📊 JPI status : Schrödinger, Inc. has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
⚠️ The stock trades above the median target: it has beaten expectations. The “Hold” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 SDGR price target & analyst consensus — price $20.41
The price target · all analysts combined (3 targets)
Highest target · 1 firm of 3$20-2.0%
Median target · of 3 targets$17-16.7%
Lowest target · 1 firm of 3$13-36.3%
Current price$20.41
⭐ What the most reliable analysts say
No reliable analyst is bullish on this stock right now. A “reliable” analyst is a firm that, on this sector, hits more than 55% of its targets and beats its sector. None of them sees upside here — which is exactly why this stock is in no JPI selection.
The consensus · 3 ratings (last 6 months)
Strong Buy00%
Buy133%
Hold267%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 SDGR price target all
All 52 calls, one by one, with our verdict on each firm.
→ See all 52 targets, analyst by analyst💡 The best analysts on SDGR most reliable
Their real reliability on SDGR, firm by firm: who was right, who was wrong.
→ See their reliability on SDGRAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Schrödinger, Inc.? The JPI assistant answers using our backtest data.
🔎 Detailed analyses
✅ Historical analyst reliability on SDGR
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| BMO Capital ↗ | 71% | +20.3% | 7 |
| Piper Sandler ↗ | 40% | -8.1% | 5 |
| Citigroup ↗ | 33% | -10.7% | 6 |
| Craig-Hallum ↗ | 33% | -25.4% | 3 |
| Keybanc ↗ | 0% | -27.4% | 6 |
📊 What $1,000 invested in Schrödinger, Inc. would be worth › open the full page
In short — $1,000 invested in Schrödinger, Inc. 10 years ago would be worth $505 today, i.e. -11%/yr on average. Best year: 2023 (+92%), worst: 2021 (-56%). Price performance, excluding dividends.
If I'd invested $1,000 in Schrödinger, Inc.
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $773 | -23% |
| 3 years ago | $863 | -14% |
| 5 years ago | $204 | -80% |
Return by year (Schrödinger, Inc.)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -10% | $897 (-10%) |
| 2025 | -14% | $773 (-23%) |
| 2024 | -42% | $451 (-55%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Schrödinger, Inc.
Loading news…
📋 All analyst calls on SDGR
Filtered on — · ✕ show all
Morgan Stanley ↗
May 14, 26
■ Equal-Weight neutral · not a buy · 🎯$17
Price at call : $11.95 — gap to target +42%
Today : $20.41 — gap to target -17%
🎯 on SDGR : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : May 14, 27
matures : May 14, 27
▲ Overweight · 🎯$20
Price at call : $11.5 — upside +74%
Today : $20.41 — upside -2%
🎯 on SDGR : 0% (6 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Apr 8, 27
matures : Apr 8, 27
■ Neutral neutral · not a buy · 🎯$13
Price at call : $11.98 — gap to target +9%
Today : $20.41 — gap to target -36%
🎯 on SDGR : no call matured yet · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Mar 17, 27
matures : Mar 17, 27
▲ Buy · 🎯$24
Price at call : $18.39 — upside +31%
Today : $20.41 — upside +18%
🎯 on SDGR : 0% (1 call matured) · 📊 on Health : 55.3% · -0.8% (38 calls)
in progress (365j)
matures : Jan 8, 27
matures : Jan 8, 27
▲ Overweight · 🎯$25
Price at call : $18.39 — upside +36%
Today : $20.41 — upside +22%
🎯 on SDGR : 0% (6 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Jan 8, 27
matures : Jan 8, 27
■ Neutral neutral · not a buy · 🎯$18
Price at call : $18.61 — gap to target -3%
Today : $20.41 — gap to target -12%
🎯 on SDGR : no call matured yet · 📊 on Health : 50% · +2.7% (74 calls)
in progress (365j)
matures : Jan 7, 27
matures : Jan 7, 27
B of A Securities ↗
Dec 15, 25
▲ Buy · 🎯$24
Price at call : $18.21 — upside +32%
Today : $20.41 — upside +18%
🎯 on SDGR : no call matured yet · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
▲ Overweight · 🎯$28
Price at call : $20.72 — upside +35%
Today : $20.41 — upside +37%
🎯 on SDGR : 0% (6 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
in progress (365j)
matures : Oct 8, 26
matures : Oct 8, 26
See the other 44 calls, newest to oldest
Goldman Sachs ↗
Sep 30, 25
■ Neutral neutral · not a buy · 🎯$19
Price at call : $20.06 — gap to target -5%
Today : $20.41 — gap to target -7%
🎯 on SDGR : no call matured yet · 📊 on Health : 51% · +5.1% (102 calls)
in progress (365j)
matures : Sep 30, 26
matures : Sep 30, 26
Morgan Stanley ↗
Aug 18, 25
■ Equal-Weight neutral · not a buy · 🎯$19
Price at call : $19.4 — gap to target -2%
Today : $20.41 — gap to target -7%
🎯 on SDGR : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Aug 18, 26
matures : Aug 18, 26
■ Neutral neutral · not a buy · 🎯$20
Price at call : $19.38 — gap to target +3%
Today : $20.41 — gap to target -2%
🎯 on SDGR : 33% (6 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
in progress (365j)
matures : Aug 15, 26
matures : Aug 15, 26
▲ Overweight · 🎯$25
Price at call : $19.45 — upside +29%
Today : $20.41 — upside +22%
Expected +29% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 0% (1 call matured) · 📊 on Health : 37.3% · -8.4% (150 calls)
-9.6%
stock -10% · XLV +25%
matured Aug 14, 26
▲ Overweight · 🎯$30
Price at call : $21.14 — upside +42%
Today : $20.41 — upside +47%
Expected +42% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 0% (6 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
-23.7%
stock -24% · XLV +17%
matured Jul 14, 26
▲ Overweight · 🎯$32
Price at call : $25.21 — upside +27%
Today : $20.41 — upside +57%
Expected +27% · Actual -52% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 0% (6 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
-52.2%
stock -52% · XLV +8%
matured Apr 16, 26
Piper Sandler ↗
Feb 27, 25
▲ Overweight · 🎯$45
Price at call : $22.25 — upside +102%
Today : $20.41 — upside +120%
Expected +102% · Actual -46% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 40% (5 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-45.8%
stock -46% · XLV +9%
matured Feb 27, 26
▲ Overweight · 🎯$27
Price at call : $24.07 — upside +12%
Today : $20.41 — upside +32%
Expected +12% · Actual -35% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 0% (6 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
-35.5%
stock -35% · XLV +7%
matured Jan 24, 26
BMO Capital ↗
Nov 13, 24
▲ Outperform · 🎯$28
Price at call : $20.37 — upside +37%
Today : $20.41 — upside +37%
Expected +37% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 71% (7 calls matureds) · 📊 on Health : 43.9% · -2.1% (66 calls)
-13.4%
stock -13% · XLV +5%
matured Nov 13, 25
BMO Capital ↗
Oct 17, 24
▲ Outperform · 🎯$25
Price at call : $17.8 — upside +40%
Today : $20.41 — upside +22%
Expected +40% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on SDGR : 71% (7 calls matureds) · 📊 on Health : 43.9% · -2.1% (66 calls)
+23.5%
stock +23% · XLV -5%
matured Oct 17, 25
Morgan Stanley ↗
Aug 21, 24
■ Equal-Weight neutral · not a buy · 🎯$30
Price at call : $19.49 — gap to target +54%
Today : $20.41 — gap to target +47%
🎯 on SDGR : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Aug 21, 25
matures : Aug 21, 25
▲ Overweight · 🎯$25
Price at call : $21.56 — upside +16%
Today : $20.41 — upside +22%
Expected +16% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 0% (6 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
-2.5%
stock -3% · XLV -8%
matured Jul 11, 25
Leerink Partners ↗
Jul 2, 24
▲ Outperform · 🎯$29
Price at call : $20.1 — upside +44%
Today : $20.41 — upside +42%
Expected +44% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 100% (1 call matured) · 📊 on Health : 50% · -5.3% (10 calls)
+5.1%
stock +5% · XLV -5%
matured Jul 2, 25
▲ Buy · 🎯$37
Price at call : $23.68 — upside +56%
Today : $20.41 — upside +81%
Expected +56% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 33% (6 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
+9.7%
stock +10% · XLV -2%
matured May 2, 25
Craig-Hallum ↗
May 2, 24
▲ Buy · 🎯$30
Price at call : $23.68 — upside +27%
Today : $20.41 — upside +47%
Expected +27% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 50% (2 calls matureds) · 📊 on Health : 60.9% · +21.4% (23 calls)
+9.7%
stock +10% · XLV -2%
matured May 2, 25
▲ Buy · 🎯$39
Price at call : $25.24 — upside +55%
Today : $20.41 — upside +91%
Expected +55% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 33% (6 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
-15.8%
stock -16% · XLV +2%
matured Mar 1, 25
Goldman Sachs ↗
Mar 1, 24
■ Neutral neutral · not a buy · 🎯$26
Price at call : $25.24 — gap to target +3%
Today : $20.41 — gap to target +27%
🎯 on SDGR : no call matured yet · 📊 on Health : 51% · +5.1% (102 calls)
in progress (365j)
matures : Mar 1, 25
matures : Mar 1, 25
▲ Overweight · 🎯$33
Price at call : $26.81 — upside +23%
Today : $20.41 — upside +62%
Expected +23% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 0% (6 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
-20.8%
stock -21% · XLV +2%
matured Feb 28, 25
▲ Buy · 🎯$39
Price at call : $26.81 — upside +45%
Today : $20.41 — upside +91%
Expected +45% · Actual -21% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 33% (6 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
-20.8%
stock -21% · XLV +2%
matured Feb 28, 25
B of A Securities ↗
Feb 29, 24
■ Neutral neutral · not a buy · 🎯$32
Price at call : $26.81 — gap to target +19%
Today : $20.41 — gap to target +57%
🎯 on SDGR : no call matured yet · 📊 on Health : 51.3% · +3.0% (152 calls)
in progress (365j)
matures : Feb 28, 25
matures : Feb 28, 25
Piper Sandler ↗
Feb 29, 24
▲ Overweight · 🎯$50
Price at call : $25.46 — upside +96%
Today : $20.41 — upside +145%
Expected +96% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 40% (5 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-12.4%
stock -12% · XLV +3%
matured Feb 28, 25
▲ Outperform · 🎯$42
Price at call : $27.19 — upside +54%
Today : $20.41 — upside +106%
Expected +54% · Actual -11% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 0% (1 call matured) · 📊 on Health : 55.3% · -0.8% (38 calls)
-11.5%
stock -11% · XLV +6%
matured Jan 25, 25
Craig-Hallum ↗
Jan 19, 24
▲ Buy · 🎯$35
Price at call : $27.39 — upside +28%
Today : $20.41 — upside +71%
Expected +28% · Actual -22% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 50% (2 calls matureds) · 📊 on Health : 60.9% · +21.4% (23 calls)
-22.1%
stock -22% · XLV +2%
matured Jan 18, 25
▲ Overweight · 🎯$38
Price at call : $31.6 — upside +20%
Today : $20.41 — upside +86%
Expected +20% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 0% (6 calls matureds) · 📊 on Health : 25.2% · -18.3% (107 calls)
-29.6%
stock -30% · XLV +11%
matured Dec 4, 24
Morgan Stanley ↗
Nov 13, 23
■ Equal-Weight neutral · not a buy · 🎯$51
Price at call : $27.77 — gap to target +84%
Today : $20.41 — gap to target +150%
🎯 on SDGR : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Nov 12, 24
matures : Nov 12, 24
Morgan Stanley ↗
Aug 4, 23
■ Equal-Weight neutral · not a buy · 🎯$52
Price at call : $38.05 — gap to target +37%
Today : $20.41 — gap to target +155%
🎯 on SDGR : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Aug 3, 24
matures : Aug 3, 24
BMO Capital ↗
Aug 3, 23
▲ Outperform · 🎯$67
Price at call : $39.76 — upside +69%
Today : $20.41 — upside +228%
Expected +69% · Actual -52% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 71% (7 calls matureds) · 📊 on Health : 43.9% · -2.1% (66 calls)
-52.2%
stock -52% · XLV +11%
matured Aug 2, 24
Morgan Stanley ↗
Jun 29, 23
■ Equal-Weight neutral · not a buy · 🎯$52
Price at call : $47.6 — gap to target +9%
Today : $20.41 — gap to target +155%
🎯 on SDGR : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Jun 28, 24
matures : Jun 28, 24
▲ Buy · 🎯$50
Price at call : $27.74 — upside +80%
Today : $20.41 — upside +145%
Expected +80% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 33% (6 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
-14.5%
stock -14% · XLV +7%
matured May 7, 24
Morgan Stanley ↗
Mar 10, 23
■ Equal-Weight neutral · not a buy · 🎯$39
Price at call : $23.47 — gap to target +66%
Today : $20.41 — gap to target +91%
🎯 on SDGR : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Mar 9, 24
matures : Mar 9, 24
BMO Capital ↗
Mar 1, 23
▲ Outperform · 🎯$78
Price at call : $24.6 — upside +217%
Today : $20.41 — upside +282%
Expected +217% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 71% (7 calls matureds) · 📊 on Health : 43.9% · -2.1% (66 calls)
+3.5%
stock +4% · XLV +14%
matured Feb 29, 24
▲ Buy · 🎯$51
Price at call : $24.18 — upside +111%
Today : $20.41 — upside +150%
Expected +111% · Actual +9% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 33% (6 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
+9.4%
stock +9% · XLV +5%
matured Jan 31, 24
Piper Sandler ↗
Jan 19, 23
▲ Overweight · 🎯$87
Price at call : $23.1 — upside +277%
Today : $20.41 — upside +326%
Expected +277% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on SDGR : 40% (5 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
+18.6%
stock +19% · XLV +5%
matured Jan 19, 24
BMO Capital ↗
Nov 4, 22
▲ Outperform · 🎯$83
Price at call : $20.61 — upside +303%
Today : $20.41 — upside +307%
Expected +303% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on SDGR : 71% (7 calls matureds) · 📊 on Health : 43.9% · -2.1% (66 calls)
+34.2%
stock +34% · XLV -3%
matured Nov 4, 23
Morgan Stanley ↗
Nov 4, 22
■ Equal-Weight neutral · not a buy · 🎯$38
Price at call : $20.92 — gap to target +82%
Today : $20.41 — gap to target +86%
🎯 on SDGR : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Nov 4, 23
matures : Nov 4, 23
Morgan Stanley ↗
Sep 9, 22
■ Equal-Weight neutral · not a buy · 🎯$39
Price at call : $28.05 — gap to target +39%
Today : $20.41 — gap to target +91%
🎯 on SDGR : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Sep 9, 23
matures : Sep 9, 23
Morgan Stanley ↗
Aug 24, 22
■ Equal-Weight neutral · not a buy · 🎯$33
Price at call : $28.48 — gap to target +16%
Today : $20.41 — gap to target +62%
🎯 on SDGR : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Aug 24, 23
matures : Aug 24, 23
Piper Sandler ↗
Jul 26, 22
▲ Overweight · 🎯$86
Price at call : $31.5 — upside +173%
Today : $20.41 — upside +321%
Expected +173% · Actual +54% · Reason (≥ +15%) : ✓ Yes
🎯 on SDGR : 40% (5 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
+54.1%
stock +54% · XLV +4%
matured Jul 26, 23
Morgan Stanley ↗
May 5, 22
■ Equal-Weight neutral · not a buy · 🎯$34
Price at call : $25.03 — gap to target +36%
Today : $20.41 — gap to target +67%
🎯 on SDGR : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : May 5, 23
matures : May 5, 23
▲ Buy · 🎯$55
Price at call : $36.12 — upside +52%
Today : $20.41 — upside +169%
Expected +52% · Actual -32% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 33% (6 calls matureds) · 📊 on Health : 43.8% · -5.4% (105 calls)
-31.9%
stock -32% · XLV -2%
matured Mar 1, 23
Morgan Stanley ↗
Nov 19, 21
■ Equal-Weight neutral · not a buy · 🎯$49
Price at call : $40.8 — gap to target +20%
Today : $20.41 — gap to target +140%
🎯 on SDGR : no call matured yet · 📊 on Health : 55.5% · +4.6% (182 calls)
in progress (365j)
matures : Nov 19, 22
matures : Nov 19, 22
Piper Sandler ↗
Nov 19, 21
▲ Overweight · 🎯$87
Price at call : $40.8 — upside +113%
Today : $20.41 — upside +326%
Expected +113% · Actual -55% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 40% (5 calls matureds) · 📊 on Health : 45.8% · +6.9% (249 calls)
-54.9%
stock -55% · XLV +1%
matured Nov 19, 22
BMO Capital ↗
May 14, 20
▲ Outperform · 🎯$67
Price at call : $57 — upside +18%
Today : $20.41 — upside +228%
Expected +18% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on SDGR : 71% (7 calls matureds) · 📊 on Health : 43.9% · -2.1% (66 calls)
+7.8%
stock +8% · XLV +23%
matured May 14, 21
BMO Capital ↗
Mar 2, 20
▲ Outperform · 🎯$65
Price at call : $44.75 — upside +45%
Today : $20.41 — upside +218%
Expected +45% · Actual +139% · Reason (≥ +15%) : ✓ Yes
🎯 on SDGR : 71% (7 calls matureds) · 📊 on Health : 43.9% · -2.1% (66 calls)
+138.5%
stock +139% · XLV +17%
matured Mar 2, 21
Frequently asked questions
Should I buy Schrödinger, Inc. stock?
This isn't buy advice. For Schrödinger, Inc., the analyst consensus is "Hold", with an average price target of $17.00 (-17% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 71% of the time (7 calls tracked on Schrödinger, Inc.). We show the numbers — you decide.
Is it too late to buy Schrödinger, Inc.? How high can it go?
The most bullish analyst target on Schrödinger, Inc. is $20.00 (-2% above today's price); the average is $17.00. That's the upside they see. Check how reliable those analysts have actually been on Schrödinger, Inc. on our site before trusting it.
Is Schrödinger, Inc. still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 5 analysts have a real record on Schrödinger, Inc., the best hitting 71% over 7 calls. Current consensus: "Hold". Make your call on data, not noise.
What has Schrödinger, Inc.'s past performance been?
Historical returns and a "how much if I had invested" calculator: SDGR performance & returns.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX